跳至主要内容
临床试验/EUCTR2010-019982-27-NL
EUCTR2010-019982-27-NL进行中(未招募)不适用

Targeted therapy selection based on tumor tissue kinase activity profiles for patients with advanced solid malignancies, an exploratory study

VU medical center0 个研究点目标入组 45 人开始时间: 2010年4月29日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Advanced solid malignancy, minimum age 18 years, no standard therapeutic options available, life expectancy of at least 12 weeks, measurable disease with at least one lesion assessable for biopsy.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Cardiovascular conditions including congestive heartfailure NYHA class >2, recent myocardial infarction or uncontrolled coronary artery disease, uncontrolled hypertension; uncontrolled infections; anticancer treatment during study or within 4 weeks of start of study treatment.

研究者

发起方
VU medical center

相似试验